Reliable and fast assays are prerequisite for rapidly identifying infectious agents such as emerging viruses, zoonotically transmitted or otherwise rare and unusual viruses in order to take appropriate epidemiologic actions and/or to choose the best treatment. However, detection and identification of viruses without specific knowledge about their genome can be challenging.

We developed an assay that combines virus capsid preparation with generic PCR. The first step is the physical and biochemical purification of a given sample by targeted digestion of contaminating host nucleic acids. This is followed by a degenerate oligonucleotide primer (DOP) PCR. The primer population is optimized for the detection of virus-sized genomes. Products can be identified by cloning and sequencing or by subjecting the PCR products to high throughput sequencing. Various DNA viruses (including HSV, VZV, SV40, AAV, EBV, parvoviruses and hepatitis B) and RNA viruses (including HTLV-1 and HTLV-2, several animal retroviruses, poliovirus, hepatitis A, a human corona virus, human metapneumovirus and influenza virus) were detected in cell cultures and clinical samples.

This novel technique requires no prior sequence information to amplify viral genomes, but nonetheless be able to amplify at least a portion of each viral genome. It can detect viruses in a variety of samples using only one aliquot of the sample per assay. These features render it ideal for virus discovery and detection of virus in samples for which other methods have failed. The ability of the DOP to detect all viruses, human and zoonotic, in parallel, is also a useful asset in the context of emerging infectious diseases, which often are of zoonotic origin. Another application is the identification of viral agents in immuno-compromised patients, who often suffer from unusual infections. Moreover, generic detection of viral agents maybe useful in assuring the safety of regulated products such as cell culture based vaccines.
